Alzheimers research shows period pain-killer completely reverses memory loss
A study in mice found that the anti-inflammatory drug mefenamic acid reversed memory loss and brain inflammation in an Alzheimers disease model by targeting the NLRP3 inflammasome. Researchers caution that effects in humans are unknown and plan early-phase II trials, highlighting the potential of repurposing an existing drug to accelerate dementia drug development.